Know What's Happening in Healthcare
Know What's Happening in Healthcare
Healthcare Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
Gilead to acquire Germany’s Tubulis for up to $5B, bolstering oncology pipeline
Gilead Sciences announced it will buy Tubulis GmbH for up to $5 billion, adding the biotech’s antibody‑drug conjugate platform to its portfolio. The deal follows Gilead’s recent $7.8 billion purchase of Arcellx and a $2 billion acquisition of Ouro Medicines as it pivots toward cancer therapies. Tubulis’ lead ADC candidate will join Gilead’s expanding oncology roster.
Also developing:
By the numbers: Neurocrine Biosciences acquires Soleno Therapeutics for $2.9B
At HIMSS26, health leaders emphasized that digital tools must prioritize people, enhancing patient care while easing clinicians' administrative load. The consensus highlighted human‑centered design as essential for technology adoption and workflow efficiency. Case studies showed nurse‑led dashboards cutting order entry time by 20 percent, proving ROI when users drive development. Stakeholders agreed that privacy protection and cognitive load reduction are non‑negotiable for sustainable innovation.
1/ The Final 2027 Rate Notice will be welcome news for those battered Medicare advantage stocks The Final notice comes in at 239bps better than the Advance notice (when asked recently, I hazarded it would be 150-200bps better) let's revisit this string...
Century Health is teaming with Virginia Commonwealth University to build an AI‑enabled clinical research database on steatotic liver disease, encompassing conditions such as MASLD, ALD and MetALD. The platform will pull structured and unstructured data from electronic health records, covering...
The Maine House unanimously advanced Rep. Julie McCabe’s LD 2103, mandating hospitals adopt cybersecurity plans aligned with DHS and CISA best practices. The bill requires prompt law‑enforcement notification, backup communication systems, and annual staff training. It responds to spring cyber‑attacks that...
:max_bytes(150000):strip_icc():format(jpeg)/i-think-im-depressed-now-what-1066902-final-31-7471c17d8128411886076c5ebe4b7782.png)
Depression symptoms should first be evaluated by a family doctor to exclude medical conditions such as thyroid disorders or medication side effects. If the primary care clinician rules out physical causes, they typically prescribe an antidepressant or refer the patient...
Manual record requests still drain time from practices. David Cohen explains how Greenway Health is working with Moxie to automate provider-to-payer data transparency — turning chart retrieval from a task into a workflow. 🔗https://t.co/Nb90e3GrsC @greenway #EHRstrategy #HITSM https://t.co/c3HJsXikz6
The Health Care Voices #CareTalk episode, hosted by Laura Packard on April 6, 2026, equips patients with practical steps to lobby legislators for better health care. Mollie Montague of the American Cancer Society Cancer Action Network explains how everyday advocates can influence...
Researchers analyzed 33 studies involving more than 2,000 participants and found that spending time outdoors—whether in real, virtual or image form—significantly lowers low mood and enhances emotional well‑being. The findings, published in Environmental Research & Public Health, give weight to...
Martha Ongwane, a mother in northern Malawi, moved from suicidal thoughts to a supportive relationship with her autistic daughter Rachael after the family accessed care at Saint John of God. The story underscores the scarcity of autism services in low‑resource...
U.S. President Donald Trump announced a sweeping 100% tariff on select pharmaceutical imports, prompting alarm across the global supply chain. Jefferies analysts argue that Indian generic exporters will largely escape the levy, though some specialty products may face limited duties....
Colorado lawmakers are advancing a second bill in two years that would carve out orphan drugs—medicines for rare diseases—from any price caps imposed by the state Prescription Drug Affordability Board. The board, created to curb soaring prescription costs, could otherwise...
XRP Healthcare announced that its XRPHAI utility token will list on MEXC on April 8, 2026, and activate a Phase 1 rewards system the next day. The token powers the XRPH AI platform, which aims to incentivize real‑world health engagement across...
Massachusetts Health and Human Services Secretary Kiame Mahaniah warned that insurers are dropping GLP‑1 weight‑loss drugs to save $46 million annually, but he expects a major price crash within two to three years that will bring back full coverage for all...
A new study in Science by St. Jude researchers reveals that tumors suppress dendritic cell function by crippling mitochondrial fitness, undermining the body’s antitumor immunity. Restoring mitochondrial activity in dendritic cells reactivates their ability to prime immune responses and dramatically...
The DIG‑RHD trial, presented at ACC 2026, randomized 1,759 patients with symptomatic rheumatic heart disease in India to digoxin or placebo. Over a median 2.1‑year follow‑up, digoxin achieved a 4.1‑percentage‑point absolute reduction in the composite of all‑cause death or new‑onset/worsening...
Researchers at Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) launched MAGNET-AD, an AI platform that predicts Alzheimer’s disease up to two decades before clinical onset. The system leverages massive multimodal health datasets and a spatiotemporal graph neural network, delivering...
Mayo Clinic scientists have created a lipid‑based nanocarrier that transports everolimus and vinorelbine across the blood‑brain barrier, extending survival more than twofold in patient‑derived glioblastoma models. The preclinical breakthrough could reshape treatment strategies for the deadliest brain cancer.
The FDA approved a set of modifications to the iPLEDGE Risk Evaluation and Mitigation Strategy on February 9, 2026, aimed at easing administrative burdens while preserving safety for isotretinoin users. Key changes include allowing home pregnancy tests during and after...
Hims & Hers disclosed a sophisticated social‑engineering breach that compromised its third‑party customer‑service platform from February 4‑7, 2026. Hackers accessed service tickets, exposing customer names and email addresses, but the firm confirmed that electronic medical records and provider communications were untouched....
A new multinational INTERASPIRE study of 4,548 coronary artery disease (CAD) patients found chronic kidney disease (CKD) is under‑detected and undertreated. Relying solely on eGFR missed about half of CKD cases, while adding urinary albumin/creatinine ratio (UACR) captured the majority....
The FDA’s Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) now requires manufacturers to supply prepaid mail‑back envelopes (MBEs) for safe opioid disposal, with pharmacies able to order them starting March 31 2025. The REMS education program, funded by unrestricted grants, offers...
UCLA researchers unveiled MethylScan, a low‑cost blood test that analyzes cell‑free DNA methylation to detect multiple cancers and liver disorders in a single sample. By using methylation‑sensitive enzymes to strip away background DNA, the assay reduces sequencing needs to about...
PillBot: The Swallowable #Robot Camera Transforming the Future of Endoscopy by @pascal_bornet #HealthTech #Tech #Technology #EmergingTech #TechForGood https://t.co/FnSO96W0A0
U.S. digital health funding surged to $4.0 billion in Q1 2025, spread across 110 deals with an average size of $36.7 million, the highest since late 2021. Nearly 60% of that capital was captured by just 12 companies securing $100 million‑plus mega deals, including Whoop’s...
Under-the-skin Tepezza comparable to infused version in key study, Amgen says https://t.co/rOQqbRmEpL $AMGN $VRDN - 25%
The Los Angeles Area Chamber of Commerce, together with its CEO Council, launched a $350,000 employer‑led workforce initiative called “A Paradigm Shift” to train students for high‑demand jobs, beginning with health care. Partnering with the Los Angeles Community College District,...
Scientists from St. Jude Children’s Research Hospital, the American Society for Hematology and the Munich Leukemia Laboratory launched the ASH HematOmics (ASHOP) platform, uniting genomics, transcriptomics and clinical data from 5,960 blood‑cancer patients. The open resource combines whole‑genome and whole‑transcriptome...
UCLA researchers introduced MethylScan, a blood test that reads cell‑free DNA methylation to flag multiple cancers and liver diseases in a single assay. In a cohort of 1,061 participants the test achieved 98% specificity, detecting about 63% of cancers overall...
The 2026 Consolidated Appropriations Act forces pharmacy benefit managers (PBMs) to pass 100% of rebates, fees and discounts through to employer‑sponsored health plans, ending spread‑pricing and increasing transparency. To protect revenue, PBMs will lean on more aggressive formulary tiering, expanded...
Amgen announced that its subcutaneous on‑body injector version of Tepezza, called Tepezza OBI, met both primary and key secondary endpoints in a late‑stage trial, showing 77% of patients achieved a meaningful reduction in eye bulging. The efficacy was comparable to...
Private equity in health care and life sciences faces a turbulent 2026 as the new administration rolls back ACA subsidies and implements the One Big Beautiful Bill Act, slashing Medicaid spending by roughly $800 billion over the next decade. The loss...
VDyne received FDA approval for an investigational device exemption to launch its pivotal TRIVITA trial of a transcatheter tricuspid valve replacement system. The study will assess safety and efficacy in patients with severe symptomatic tricuspid regurgitation, a condition affecting roughly...
On August 25, 2026 the FDA will host a hybrid Patient‑Focused Drug Development meeting dedicated to non‑healing chronic wounds. The public session runs from 10 a.m. to 4:30 p.m. ET and combines a virtual webcast with an in‑person gathering at the White Oak Campus....
White House Budget Bans COVID Air Travel Mask Mandates — Four Years After They Already Ended - View from the Wing https://t.co/UMKew7Rr5W
The White House’s FY budget proposes a sizable increase for the FDA, positioning Dr. Robert Makary to spearhead regulatory reforms aimed at accelerating U.S. biotech development. The plan includes policy changes that would shorten clinical‑trial timelines, lower fees for early‑stage...
Rural healthcare organizations are bracing for reduced Medicaid funding while eyeing the $10 billion‑per‑year Rural Health Transformation Program. Tight cash reserves are driving IT leaders to prioritize short‑term resilience, cost‑cutting measures and rapid‑ROI technologies such as AI‑enabled documentation, cloud migration, and...
Interest in medicinal cannabis for children with autism, ADHD and Tourette's has grown, prompting the Australian Therapeutic Goods Administration to confirm that doctors are prescribing it for these conditions. While parents hope it could reduce reliance on stimulants, antidepressants and...
Could a plant-based diet make your bones weaker? In this meta-analysis that looked at 529,672 participants (average ages of 46–63; 57% women, 43% men), both vegetarian diets and vegan diets were associated with a HIGHER risk of hip fracture: https://t.co/3u18PxPmrk...
A new analysis presented at CROI 2026 used International Epidemiology Databases to Evaluate AIDS (IeDEA) data from Africa, Asia‑Pacific, and Latin America, covering over 90% of the world’s children with HIV. The study found that dolutegravir initiates modest early weight gain...
AstraZeneca announced that its IL‑33 monoclonal antibody tozorakimab achieved its primary endpoints in two Phase III COPD trials, Oberon and Titania. The drug significantly reduced the annual rate of moderate‑to‑severe exacerbations versus placebo across former and current smokers. AstraZeneca positions tozorakimab...
Health policy experts are warning that the Centers for Medicare & Medicaid Services is exploring automatic enrollment of Medicare beneficiaries into Medicare Advantage (MA) plans. They argue the move could curtail seniors' ability to choose alternative coverage and drive up...
Mayo Clinic researchers introduced a new method called the Ratio of Immunogenicity (ROI) to identify proteins that provoke strong immune responses. By measuring protein abundance and immune activation, the ROI ranks proteins from most to least immunogenic, revealing that mitochondrial...
Legion Health, a San Francisco startup, received Utah regulatory approval to let its AI chatbot renew psychiatric prescriptions for a limited set of antidepressants such as Prozac and Zoloft. The system can only prescribe drugs previously authorized by a human...
The Holland Foundation for Sight Restoration is scaling its Cincinnati Protocol for ocular surface stem‑cell transplantation by establishing “centers of excellence” and expanding surgeon education. To date, five centers—from Cincinnati to UC Irvine, Virginia Eye Consultants, and Massachusetts Eye and...
In a recent HFMA podcast, senior editor Erika Grotto and FinThrive’s Jonathan Wiik dissect a high‑profile antitrust lawsuit targeting alleged price‑fixing among hospital providers. The discussion also explores how artificial intelligence can be woven into the patient‑experience journey to boost...
Just because peptides are manufactured badly and contain toxins does not mean that they will be safe and effective if manufactured well. Seriously, just eat whole foods, exercise, and maybe take a damn statin.
The U.S. Supreme Court granted certiorari in Hikma v. Amarin, a dispute over whether a generic maker can be liable for inducing patent infringement when it markets a “skinny‑label” version that omits a patented use. The case spotlights the broader...
Cedars‑Sinai researchers have created a geospatial algorithm that identifies clusters of sudden cardiac arrests and recommends optimal public AED locations within 200 meters of those hotspots. The model analyzed incidents from 2012‑2023 in Ventura County, California, and Multnomah County, Oregon,...
Health Level Seven International (HL7) has launched the Caliper FHIR Accelerator implementation community to accelerate real‑world exchange of data from medical and personal health devices. The multi‑stakeholder group builds on the Gemini Device Interoperability Program and will use FHIR standards,...
About 80% of breast biopsies in the United States turn out benign, prompting calls for less invasive diagnostics. Researchers have developed a hand‑held device that merges traditional ultrasound with diffuse optical tomography (DOT), which maps blood hemoglobin and oxygen levels...
